Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 21, 2017; 23(23): 4262-4269
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4262
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4262
Table 3 Comparison of prevalence of colorectal neoplasm between endoscopic submucosal dissection group and fecal immunochemical test group n (%)
| Colorectal neoplasm | ESD group (n = 158) | FIT group (n = 158) | P value |
| Adenoma (< 1 cm) | 53 (33.5) | 66 (41.8) | 0.164 |
| Advanced adenoma | 17 (10.8) | 24 (15.2) | 0.315 |
| Large tubular adenoma (≥ 1 cm) | |||
| Tubulovillous/villous adenoma | |||
| High grade dysplasia | |||
| Number of adenomas | 0.507 | ||
| 1 to 3 | 59 (37.3) | 71 (44.9) | |
| ≥ 4 | 11 (7.0) | 19 (12.0) | |
| Cancer or NET | 10 (6.3) | 10 (6.3) | 0.999 |
- Citation: Tsuchida C, Yoshitake N, Kino H, Kaneko Y, Nakano M, Tsuchida K, Tominaga K, Sasai T, Masuyama H, Yamagishi H, Imai Y, Hiraishi H. Clinical importance of colonoscopy in patients with gastric neoplasm undergoing endoscopic submucosal dissection. World J Gastroenterol 2017; 23(23): 4262-4269
- URL: https://www.wjgnet.com/1007-9327/full/v23/i23/4262.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i23.4262